Editions Ecce Terra CAMPARIS electron GFP microprobe facility Microscopie Confocale

Laboratoire de Microsondes Chromogenic in situ hybridization (CISH) – Microscope Electronique à Balayage

fallback-image

Inhibitor Assay

Human Anti-Salmonella IgG Antibody Assay Kit

6125 1 kit
EUR 663.78
Description: Human Anti-Salmonella IgG Antibody Assay Kit

Human IgG antibody Laboratories manufactures the inhibitor assay reagents distributed by Genprice. The Inhibitor Assay reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact inhibitor assay. Other Inhibitor products are available in stock. Specificity: Inhibitor Category: Assay

Mouse Anti-SEA IgG Antibody Assay Kit

1 kit
EUR 663.78
Description: Mouse Anti-SEA IgG Antibody Assay Kit

Mouse Anti-dsDNA IgG Antibody Assay Kit

1 kit
EUR 681.18
Description: Mouse Anti-dsDNA IgG Antibody Assay Kit

Mouse Anti-ssDNA IgG Antibody Assay Kit

1 kit
EUR 681.18
Description: Mouse Anti-ssDNA IgG Antibody Assay Kit

True north Cryobox 0.2mLNatural

PK10
EUR 172.8

True north Cryobox 0.5mLNatural

PK10
EUR 153.6

True north Cryobox1.5/2mLNatural

PK10
EUR 100.8

True north Cryobox 5mLNatural

PK10
EUR 153.6

Proteins information

NAMPT Inhibitor Screening Assay Kit

71276-2 384 rxns.
EUR 930
Description: The NAMPT Inhibitor Screening Assay Kit is designed to measure NAMPT activity for screening and profiling applications. The key to the assay is a coupled reaction including NMNAT and ADH. NAMPT converts nicotinamide substrate to nicotinamide mononucleotide (NMN) via PRPP. NMNAT subsequently converts NMN to NAD+ , which is reduced by ADH to NADH, permitting detection of the fluorescent NADH signal.

BAZ2B Inhibitor Screening Assay Kit

32600 384 rxns.
EUR 510
Description: The BAZ2B Inhibitor Screening Assay Kit is designed to measure the inhibition of BAZ2B binding to its substrate. The key to the BAZ2B Inhibitor Screening Assay Kit is the highly specific binding of the BAZ2B bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BAZ2B and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

BRPF3 Inhibitor Screening Assay Kit

32608 384 rxns.
EUR 1025
Description: The BRPF3 Inhibitor Screening Assay Kit is designed to measure the inhibition of BRPF3 binding to its substrate. The key to the BRPF3 Inhibitor Screening Assay Kit is the specific binding of the BRPF3 bromodomain to an acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRPF3 and an inhibitor of choice is incubated with the biotinylated substrate. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts

CECR2 Inhibitor Screening Assay Kit

32611 384 rxns.
EUR 1025
Description: The CECR2 Inhibitor Screening Assay Kit is designed to measure the inhibition of CECR2 binding to its substrate. The key to the CECR2 Inhibitor Screening Assay Kit is the highly specific binding of the CECR2 bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing CECR2 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

ATAD2A Inhibitor Screening Assay Kit

32601 384 rxns.
EUR 1025
Description: The ATAD2A Inhibitor Screening Assay Kit is designed to measure the inhibition of ATAD2A binding to its substrate. The key to the ATAD2A Inhibitor Screening Assay Kit is a specific binding of the ATAD2A bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing ATAD2A and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

ATAD2B Inhibitor Screening Assay Kit

32605 384 rxns.
EUR 1025
Description: The ATAD2B Inhibitor Screening Assay Kit is designed to measure the inhibition of ATAD2B binding to its substrate. The key to the kit is the specific binding of the ATAD2B bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing ATAD2B and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

TRIM24 Inhibitor Screening Assay Kit

32606 384 rxns.
EUR 1025
Description: The TRIM24 Inhibitor Screening Assay Kit is designed to measure the inhibition of TRIM24 binding to its substrate. The key to the TRIM24 Inhibitor Screening Assay Kit is the specific binding of the TRIM24 bromodomain to an acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing TRIM24 and an inhibitor of choice is incubated with the biotinylated substrate. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

CREBBP Inhibitor Screening Assay Kit

32607 384 rxns.
EUR 510
Description: The CREBBP Inhibitor Screening Assay Kit is designed to measure the inhibition of CREBBP binding to its substrate. The key to the CREBBP Inhibitor Screening Assay Kit is a specific binding of the CREBBP bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing CREBBP and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

L3MBTL1 Inhibitor Screening Assay Kit

55100 384 rxns.
EUR 535
Description: The L3MBTL1 Inhibitor Screening Assay Kit is designed to measure the inhibition of L3MBTL1 binding to its substrate. The key to the kit is the specific binding of the L3MBTL1 MBT domain to the methylated-peptide substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing L3MBTL1 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

SMARCA2 Inhibitor Screening Assay Kit

32610 384 rxns.
EUR 510
Description: The SMARCA2 Inhibitor Screening Assay Kit is designed to measure the inhibition of SMARCA2 binding to its substrate. The key to the SMARCA2 Inhibitor Screening Assay Kit is the specific binding of the SMARCA2 bromodomain to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing SMARCA2 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

BRD3 (BD1) Inhibitor Screening Assay Kit

32513 384 rxns.
EUR 510
Description: The BRD3 (BD1) Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD3 bromodomain 1 (BD1) from binding to its substrate. The key to the BRD3 (BD1) Inhibitor Screening Assay Kit is the highly specific binding of the BRD3 bromodomain 1 to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD3 bromodomain 1 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

BRD4 (BD1) Inhibitor Screening Assay Kit

32514 384 rxns.
EUR 510
Description: The BRD4 (BD1) Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD4 bromodomain 1 (BD1) from binding to its substrate. The key to the BRD4 (BD1) Inhibitor Screening Assay Kit is the highly specific binding of the BRD4 bromodomain 1 to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD4 bromodomain 1 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

BRD9 (BD1) Inhibitor Screening Assay Kit

32519 384 rxns.
EUR 510
Description: The BRD9 Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD9 binding to its substrate. The key to the BRD9 Inhibitor Screening Assay Kit is the specific binding of the BRD9 bromodomain to an acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD9 and an inhibitor of choice is incubated with the biotinylated substrate. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

BRD2 (BD2) Inhibitor Screening Assay Kit

32522 384 rxns.
EUR 510
Description: The BRD2 (BD2) Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD2 bromodomain 2 (BD2) from binding to its substrate. The key to the BRD2 (BD2) Inhibitor Screening Assay Kit is the highly specific binding of the BRD2 bromodomain 2 to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD2 bromodomain 2 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

BRD3 (BD2) Inhibitor Screening Assay Kit

32523 384 rxns.
EUR 510
Description: The BRD3 (BD2) Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD3 bromodomain 2 (BD2) from binding to its substrate. The key to the BRD3 (BD2) Inhibitor Screening Assay Kit is the highly specific binding of the BRD3 bromodomain 2 to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD3 bromodomain 2 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

BRD4 (BD2) Inhibitor Screening Assay Kit

32524 384 rxns.
EUR 510
Description: The BRD4 (BD2) Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD4 bromodomain 2 (BD2) binding to its substrate. The key to the BRD4 (BD2) Inhibitor Screening Assay Kit is the highly specific binding of the BRD4 bromodomain 2 to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD4 bromodomain 2 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

TAF1 (BD2) Inhibitor Screening Assay Kit

32624 384 rxns.
EUR 1025
Description: The TAF1 (BD2) Inhibitor Screening Assay Kit is designed to measure the inhibition of TAF1 (BD2) binding to its substrate. The key to the TAF1 (BD2) Inhibitor Screening Assay Kit is the specific binding of the TAF1 bromodomain 2 (a.a. 1519-1651) to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing TAF1 (BD2) and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

Articles récents

septembre 2023
L M M J V S D
 123
45678910
11121314151617
18192021222324
252627282930  

Catégories

Étiquettes